Published in Ann Surg on January 01, 1968
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34
Thoracic duct drainage in organ transplantation: will it permit better immunosuppression? Transplant Proc (1979) 1.21
Pressure waves and gradients in the canine thoracic duct. J Physiol (1971) 1.00
Prolonged thoracic-duct drainage in rheumatoid arthritis and systemic lupus erythematosus. West J Med (1979) 0.93
Management of lymph fistulas in thyroid surgery. Langenbecks Arch Surg (2010) 0.90
The efficacy of closed-circuit extracorporeal filtration of thoracic duct lymph as a means of lymphocyte depletion. Clin Exp Immunol (1972) 0.81
The velocity of lymph flow in the canine thoracic duct. J Physiol (1974) 0.77
Could a simple surgical intervention eliminate HIV infection? Theor Biol Med Model (2004) 0.75
Exploring the feasibility of selective depletion of T lymphocyte subsets by whole blood immunoadsorption cytapheresis. Clin Exp Immunol (2007) 0.75
THE ROUTE OF RE-CIRCULATION OF LYMPHOCYTES IN THE RAT. Proc R Soc Lond B Biol Sci (1964) 20.20
Autoradiographic studies on the immune response.I. The kinetics of plasma cell proliferation. J Exp Med (1962) 9.43
THE MIGRATION OF LYMPHOCYTES THROUGH THE ENDOTHELIUM OF VENULES IN LYMPH NODES: AN ELECTRON MICROSCOPE STUDY. Proc R Soc Lond B Biol Sci (1964) 6.93
Radioautographic studies of small lymphocytes in the thoracic duct of the rat. Acta Haematol (1962) 3.50
On the age of human white cells in peripheral blood. Acta Physiol Scand (1954) 2.63
Alterations in Thoracic Duct Lymph Flow in Hepatic Cirrhosis: Significance in Portal Hypertension. Ann Surg (1962) 2.63
The output of lymphocytes from the thoracic duct of unanaesthetized mice. Br J Exp Pathol (1962) 2.61
Variations in the terminal portion of the human thoracic duct. AMA Arch Surg (1956) 1.38
Experimental transfusion of lymphocytes. Am J Physiol (1960) 1.36
LYMPHOCYTE LIFETIME IN WOMEN. Science (1965) 1.27
THE SUPPRESSION OF IMMUNOLOGIC ACTIVITY BY DIVERSION OF THORACIC DUCT LYMPH. Ann Surg (1964) 1.11
Cannulation of the human thoracic lymph duct. Surgery (1959) 1.10
LYMPH DRAINAGE IN PATIENTS WITH CONGESTIVE HEART FAILURE. COMPARISON WITH FINDINGS IN HEPATIC CIRRHOSIS. N Engl J Med (1963) 1.00
The thoracic duct fistula as an adjunct to immunosuppression in human renal transplantation. Transplantation (1967) 0.99
Thoracic duct fistula in human being renal transplantation. Surg Forum (1966) 0.82
Technique for cannulation of the thoracic duct. Surg Gynecol Obstet (1967) 0.82
Patterns of lymphatic drainage in the adult laboratory rat. J Anat (1971) 4.15
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34
Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46
The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest (1997) 2.28
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med (1987) 2.16
Intrarenal distribution of blood flow in the transplanted dog kidney: effect of denervation and rejection. J Clin Invest (1967) 2.14
Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med (1984) 2.03
The high cost of low-frequency events: the anatomy and economics of surgical mishaps. N Engl J Med (1981) 1.94
Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet (1981) 1.92
Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med (1975) 1.82
Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest (1997) 1.77
Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg (1984) 1.67
CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int (1997) 1.57
Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation (1995) 1.53
The effect of heterologous immune serum on canine renal homografts. Transplantation (1966) 1.52
The systemic distribution of soluble antigen injected into the footpad of the laboratory rat. Immunology (1970) 1.51
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51
Skeletal changes associated with vascular malformations. Plast Reconstr Surg (1984) 1.46
Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45
The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest (1997) 1.42
Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg (1985) 1.40
A broadening of vision: observation on the practice of surgery in a university hospital in Great Britain. Surgery (1974) 1.39
Transplant survival and patient activity data from the Human Kidney Transplant Registry. Transplant Proc (1971) 1.38
Ethical implications of renal transplants. JAMA (1967) 1.38
Non-heartbeating kidney donors. Clin Transplant (1999) 1.37
Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci U S A (1995) 1.34
Mid-face osteotomy and advancement for craniosynostosis. Plast Reconstr Surg (1968) 1.31
Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics. Transplantation (1981) 1.28
Sequential system failure after rupture of abdominal aortic aneurysms: an unsolved problem in postoperative care. Ann Surg (1973) 1.28
The sensitization of rats by allografts transplanted to alymphatic pedicles of skin. J Exp Med (1971) 1.27
Sialadenitis in childhood. Am J Surg (1978) 1.27
Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model. Transplantation (1992) 1.26
Facial fractures in children: an analysis of 122 fractures in 109 patients. Plast Reconstr Surg (1977) 1.25
Fifth report of The Human Kidney Transplant Registry. Transplantation (1967) 1.25
Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol (1999) 1.24
Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation (1993) 1.24
Major intravenous extravasation injuries. Am J Surg (1979) 1.23
Heparin and aspirin in the treatment of hyperacute rejection of renal allografts in presensitized dogs. Transplantation (1970) 1.23
Small intestine transplantation in the rat--immunology and function. Surgery (1984) 1.23
Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation (1998) 1.22
Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation (1999) 1.22
Surgical treatment of life-endangering chronic aspiration pneumonia. Use of an epiglottic flap to the arytenoids. Plast Reconstr Surg (1972) 1.21
Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats. Proc Natl Acad Sci U S A (1986) 1.21
Peripheral arterial complications of intra-aortic ballon counterpulsation. Surgery (1977) 1.16
Suppressive effects of cyclosporin A on the induction of alloreactivity in vitro and in vivo. J Immunol (1981) 1.15
On ethics and the training of the plastic surgeon. Plast Reconstr Surg (1978) 1.14
Eighth report of the Human Kidney Transplant Registry. Transplantation (1971) 1.13
Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J Immunol (1987) 1.13
Immune responses to organ allografts. III. Marked decrease in medullary thymocytes and splenic T lymphocytes after cyclosporin A treatment. Transplantation (1981) 1.13
Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts. J Immunol (1977) 1.12
The immunosuppressive effect of thoracic duct drainage in human kidney transplantation. Ann Intern Med (1970) 1.12
Rejected human renal allografts: recovery and characteristics of infiltrating cells and antibody. Transplantation (1979) 1.10
Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Am J Pathol (1998) 1.10
Late mortality and morbidity in recipients of long-term renal allografts. Transplantation (1982) 1.10
Surface properties and functional characteristics of infiltrating cells harvested from acutely rejecting cardiac allografts in inbred rats. Transplantation (1975) 1.08
Immunologic relationships between skin and kidney homografts in dogs on immunosuppressive therapy. Transplantation (1966) 1.07
Rapid regeneration of the chronically damaged facial nerve following ipsilateral free gracilis transfer. Plast Reconstr Surg (1983) 1.07
Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation (1997) 1.07
Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation (1992) 1.05
Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation (2000) 1.05
Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. Transplantation (1997) 1.04
Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. Transplantation (1983) 1.04
The role of vasoconstriction in the ischemia of renal allograft rejection. Transplantation (1968) 1.04
Introductory remarks on kidney transplantation with observations on kidney transplant registry. Transplantation (1967) 1.04
Femoral triangle sepsis in dialysis patients: frequency, management, and outcome. Ann Surg (1980) 1.02
Chronic graft rejection. Curr Opin Immunol (1994) 1.02
Early experience with anti-Tac in clinical renal transplantation. Transplant Proc (1989) 1.01
Cortical ischemia in renal allograft rejection. Surg Gynecol Obstet (1967) 1.00
Hemorrhagic pancreatitis. A fatal complication of renal transplantation. N Engl J Med (1966) 1.00
The cost of misadventures in colonic surgery. A model for the analysis of adverse outcomes in standard procedures. Am J Surg (1978) 1.00
Treatment of chronic renal failure by transplantation and dialysis: two decades of cooperation. Ann Surg (1975) 1.00
The migration of rat lymphoid cells into skin grafts. Some sensitised cells localise preferentially in specific allografts. Transplantation (1974) 1.00
Mechanisms of rejection and prolongation of vascularized organ allografts. Immunol Rev (1984) 0.99
The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity. Clin Exp Immunol (1976) 0.99
The thoracic duct fistula as an adjunct to immunosuppression in human renal transplantation. Transplantation (1967) 0.99
Renal homotransplantation in identical twins. 1955. J Am Soc Nephrol (2001) 0.98
Urologic complications in 718 renal transplant patients. Surgery (1984) 0.97
Urological complications of renal transplantation. Br J Urol (1970) 0.97
Colonic perforations after renal transplantation. J Am Coll Surg (1997) 0.96
Natural history of the leg amputee. Am J Surg (1977) 0.96
Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation (2000) 0.96
Renal transplantation: a twenty-five year experience. Ann Surg (1976) 0.95
Microtia: a microform of hemifacial microsomia. Plast Reconstr Surg (1985) 0.95
Immunoglobulin-secreting cells recovered from rejected human renal allografts. Transplantation (1982) 0.95
Sparing of suppressor cells: a critical action of cyclosporine. Transplantation (1984) 0.94
Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant (2000) 0.94
Effect of immunosuppressive therapy on the intrarenal distribution of blood flow in dog renal allograft rejection. Surg Forum (1966) 0.94
Severe pneumonia in renal transplant patients. One year's experience. Ann Intern Med (1971) 0.94
CD4 monoclonal antibodies in organ transplantation--a review of progress. Transplantation (1991) 0.94
Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg (1971) 0.93
Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg (1994) 0.93
Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats. J Immunol (1984) 0.93
Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest (1994) 0.93
Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest (1998) 0.93
Management of facial fractures in children. Clin Plast Surg (1977) 0.93